PhRMA spent $59M on search ads to shape drug pricing narrative

PhRMA, the U.S. pharmaceutical trade group, spent an estimated $59 million on search advertising over seven years to influence public opinion on prescription drug costs. The disclosure reveals a sustained, targeted effort to shape the policy debate, though the exact impact on public sentiment remains unquantified. This matters as it underscores the scale of corporate political influence ahead of drug pricing legislation.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works